Bombay Generics Private Limited, a active private limited company, was established on 01 June 1989 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1989PTC012305. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Formerly known as Osho Pharma Pvt Ltd. It upholds a compliant status. Its leadership includes Krushnakant Bhalodia (Director), Krunal Dilipkumar Sanghavi (Director), Snehalbhai Jashwantbhai Shah (Director). Past directors included Krunal Dilipkumar Sanghavi, Snehalbhai Jashwantbhai Shah, Bhavin Agarwal Jaigovindbhai. It holds ₹15.09 Cr open charges and ₹5.23 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 2404 Phase-Iv G.I.D.C. Vatva, Ahmedabad, Gujarat, 382445.
U24231GJ1989PTC012305
012305
01 June 1989
₹5.00 M
₹5.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Bombay Generics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krushnakant Bhalodia | Director | 01 Feb 2021 | Current |
| Krunal Dilipkumar Sanghavi | Director | 11 Jul 2016 | Current |
| Snehalbhai Jashwantbhai Shah | Director | 11 Jul 2016 | Current |
| Poojaben Bhalodiya | Director | 01 Feb 2021 | Current |
| Dimpal Bhalodiya | Director | 01 Feb 2021 | Current |
| Bharatkumar Babulal Patel | Director | 11 Jul 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 15 Mar 2019 | Past |
| Pramod Abcsdd | Director | 11 Jul 2016 | Past |
| Pramod Abcsdd | Director | 11 Jul 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bombay Generics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1359.34% increase. The company also saw a substantial improvement in profitability, with a 484.83% increase in profit. The company's net worth Soared by an impressive increase of 72.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Bombay Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹150,873,000.00
₹52,250,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2025 | Others | ₹15.00 Cr | Open |
| 19 Jan 1990 | Gujrat State Financial Corporation | ₹0.87 M | Open |
| 02 Sep 2023 | Others | ₹4.00 Cr | Satisfied |
| 12 Sep 2005 | Union Bank Of India | ₹1.15 Cr | Satisfied |
| 20 Nov 1990 | Union Bankl Of India | ₹0.25 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bombay Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bombay Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Generics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 150.00 M registered on 13 May 2025 with Charge ID 101100020 was modified on 30 Jul 2025. was completed.
A charge with Others amounted to Rs. 150.00 M with Charge ID 101100020 was registered on 13 May 2025. was recorded as a recent event.
The activity Bombay Generics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge registered on 02 Sep 2023 via Charge ID 100800835 with Others was fully satisfied on 06 Jul 2024. was documented.
Progress on Bombay Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on A charge with Others amounted to Rs. 40.00 M with Charge ID 100800835 was registered on 02 Sep 2023. was documented.
The CIN of Bombay Generics Private Limited is U24231GJ1989PTC012305.
Bombay Generics Private Limited is headquartered at Plot No 2404 Phase-Iv G.I.D.C. Vatva, Ahmedabad, Gujarat, 382445.
Bombay Generics Private Limited was incorporated on 01 June 1989.
The current directors of Bombay Generics Private Limited are
The primary industry of Bombay Generics Private Limited is Manufacturing.
Bombay Generics Private Limited is unlisted.
The authorized capital of Bombay Generics Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Bombay Generics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX